loadpatents
Patent applications and USPTO patent grants for Caruso; Frank S..The latest application filed is for "abuse-resistant controlled-release opioid dosage form".
Patent | Date |
---|---|
Abuse-resistant Controlled-release Opioid Dosage Form App 20190111051 - Caruso; Frank S. ;   et al. | 2019-04-18 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20180185353 - CARUSO; Frank S. | 2018-07-05 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20180169090 - CARUSO; Frank S. ;   et al. | 2018-06-21 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20170014405 - CARUSO; Frank S. ;   et al. | 2017-01-19 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20170014406 - CARUSO; Frank S. ;   et al. | 2017-01-19 |
Abuse-resistant controlled-release opioid dosage form Grant 9,511,066 - Caruso , et al. December 6, 2 | 2016-12-06 |
Abuse-resistant controlled-release opioid dosage form Grant 9,480,685 - Caruso , et al. November 1, 2 | 2016-11-01 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20160263106 - CARUSO; Frank S. ;   et al. | 2016-09-15 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20160256456 - CARUSO; Frank S. ;   et al. | 2016-09-08 |
Abuse-resistant controlled-release opioid dosage form Grant 9,358,230 - Caruso , et al. June 7, 2 | 2016-06-07 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20160151354 - CARUSO; Frank S. ;   et al. | 2016-06-02 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20160151353 - CARUSO; Frank S. ;   et al. | 2016-06-02 |
Abuse-resistant controlled-release opioid dosage form Grant 9,345,701 - Caruso , et al. May 24, 2 | 2016-05-24 |
Abuse-resistant controlled-release opioid dosage form Grant 9,283,216 - Caruso , et al. March 15, 2 | 2016-03-15 |
Abuse-resistant controlled-release opioid dosage form Grant 9,283,221 - Caruso , et al. March 15, 2 | 2016-03-15 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20160008351 - Caruso; Frank S. ;   et al. | 2016-01-14 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20160008346 - CARUSO; Frank S. ;   et al. | 2016-01-14 |
Abuse-resistant controlled-release opioid dosage form Grant 9,168,252 - Caruso , et al. October 27, 2 | 2015-10-27 |
Abuse-resistant controlled-release opioid dosage form Grant 9,161,937 - Caruso , et al. October 20, 2 | 2015-10-20 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20150258087 - Caruso; Frank S. ;   et al. | 2015-09-17 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20150258088 - CARUSO; Frank S. ;   et al. | 2015-09-17 |
Abuse-resistant controlled-release opioid dosage form Grant 9,084,729 - Caruso , et al. July 21, 2 | 2015-07-21 |
Abuse-resistant controlled-release opioid dosage form Grant 9,056,051 - Caruso , et al. June 16, 2 | 2015-06-16 |
Abuse-resistant controlled-release opioid dosage form Grant 8,969,369 - Caruso , et al. March 3, 2 | 2015-03-03 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20140194456 - CARUSO; Frank S. ;   et al. | 2014-07-10 |
Abuse-Resistant Controlled-Release Opioid Dosage Form App 20140135355 - CARUSO; Frank S. ;   et al. | 2014-05-15 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20140107146 - CARUSO; Frank S. ;   et al. | 2014-04-17 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20130172382 - Caruso; Frank S. ;   et al. | 2013-07-04 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20120252832 - Caruso; Frank S. ;   et al. | 2012-10-04 |
Abuse-resistant controlled-release opioid dosage form App 20080069881 - Caruso; Frank S. ;   et al. | 2008-03-20 |
Analgesics and methods of use App 20070129434 - Smith-Carliss; Richard ;   et al. | 2007-06-07 |
Method for the treatment of urinary incontinence Grant 7,087,619 - Caruso August 8, 2 | 2006-08-08 |
Method for the treatment of urinary incontinence App 20030199484 - Caruso, Frank S. | 2003-10-23 |
Method for the treatment of urinary incontinence Grant 6,562,835 - Caruso May 13, 2 | 2003-05-13 |
Abuse-resistant controlled-release opioid dosage form App 20030065002 - Caruso, Frank S. ;   et al. | 2003-04-03 |
Anticonvulsant containing composition for treating neuropathic pain Grant 6,406,716 - Caruso , et al. June 18, 2 | 2002-06-18 |
Composition and method combining an antidepressant with an NMDA receptor antagonist, for treating neuropathic pain App 20020035105 - Caruso, Frank S. | 2002-03-21 |
Analgesic drug composition containing a capsaicinoid and potentiator therefor Grant 6,277,398 - Caruso August 21, 2 | 2001-08-21 |
Anticonvulsant containing composition for treating neuropathic pain App 20010008889 - Caruso, Frank S. ;   et al. | 2001-07-19 |
Anticonvulsant containing composition for treating neuropathic pain Grant 6,187,338 - Caruso , et al. February 13, 2 | 2001-02-13 |
Analgesic composition and method for alleviating pain Grant 6,054,451 - Caruso April 25, 2 | 2000-04-25 |
Method and composition for treating migraine Grant 6,043,244 - Caruso March 28, 2 | 2000-03-28 |
Analgesic composition and method for treating pain Grant 6,007,841 - Caruso December 28, 1 | 1999-12-28 |
Method of alleviating pain Grant 5,919,826 - Caruso July 6, 1 | 1999-07-06 |
Method for treating migraine Grant 5,891,885 - Caruso April 6, 1 | 1999-04-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.